{
  "nbformat": 4,
  "nbformat_minor": 0,
  "metadata": {
    "colab": {
      "provenance": []
    },
    "kernelspec": {
      "name": "python3",
      "display_name": "Python 3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# üè• Bonus Task: Ethical AI Policy for Healthcare (1-Page Guideline)\n",
        "\n",
        "## Policy Title: Responsible Deployment of Clinical AI Systems (CDAS)\n",
        "\n",
        "**Goal:** To establish strict ethical and technical requirements for any AI system used in patient diagnosis, risk assessment, or treatment planning within our clinical network, ensuring patient safety, fairness, and trust.\n",
        "\n",
        "---\n",
        "\n",
        "## 1. Patient Consent Protocols (Principle of Autonomy) ü§ù\n",
        "\n",
        "We mandate a layered, dynamic approach to patient consent, acknowledging the patient's right to control their data and the use of automated systems in their care.\n",
        "\n",
        "-   **Layered Consent:** Consent must be obtained at two distinct stages:\n",
        "    -   **Data Use Consent:** Permission to use de-identified patient data for training and validating the AI model. This must be separated from clinical treatment consent.\n",
        "    -   **Decision Use Consent:** Explicit, informed consent before any automated AI output (e.g., diagnosis, risk score) is used to inform the patient‚Äôs treatment plan.\n",
        "-   **Right to Human Review:** Patients must be clearly informed of their right to **reject** an AI-generated recommendation or assessment and request a full, detailed review by a qualified human physician who is independent of the AI system development team.\n",
        "-   **Right to Opt-Out:** Patients maintain the right to withdraw consent for the use of their data in future model retraining or evaluation at any time without penalty to their ongoing care.\n",
        "\n",
        "## 2. Bias Mitigation and Fairness Strategies (Principle of Justice) ‚öñÔ∏è\n",
        "\n",
        "We commit to auditing and mitigating bias to ensure the benefits and risks of AI are distributed equitably across all patient populations.\n",
        "\n",
        "-   **Data Diversity Mandate:** All training and validation datasets must be meticulously audited to ensure they accurately reflect the target demographic population, including equitable representation across age, sex, and ethnicity. Gaps in data must be documented and addressed through synthetic data generation or targeted collection efforts.\n",
        "-   **Metric Parity:** Models must satisfy **Equalized Odds** requirements. This means the model's accuracy must be balanced across demographic groups, specifically ensuring:\n",
        "    -   Near-zero difference in **False Negative Rate (FNR)** to prevent missed diagnoses in marginalized groups.\n",
        "    -   Near-zero difference in **False Positive Rate (FPR)** to prevent unnecessary interventions or treatments in marginalized groups.\n",
        "-   **Intersectional Audit:** Fairness checks must extend beyond single protected attributes (e.g., race) to include intersectional groups (e.g., elderly women of a specific ethnic background).\n",
        "\n",
        "## 3. Transparency and Explainability Requirements (Principle of Accountability) üîç\n",
        "\n",
        "All deployed CDAS must provide meaningful explanations for their outcomes to patients, clinicians, and regulators.\n",
        "\n",
        "-   **Clinical Explainability (SHAP/LIME):** Every high-stakes diagnostic decision must be accompanied by a machine-generated **explanation (XAI)** identifying the top 3-5 clinical features (e.g., blood pressure, lab markers, imaging data) that drove the AI's specific conclusion. Clinicians must verify the fidelity of the explanation.\n",
        "-   **Mandatory Model Cards:** Prior to deployment, every CDAS must include a detailed **Model Card** accessible to the Governance Board. This card must document the model‚Äôs intended use, performance limitations, known failure modes, error rates across all audited demographic subgroups, and the date of the last successful bias audit.\n",
        "-   **Regulatory Oversight:** All policies, audit reports, and model version changes must be reported to the internal Ethics and Governance Committee for quarterly review to ensure sustained compliance with ethical standards and clinical efficacy."
      ],
      "metadata": {
        "id": "b4zpcks0Xb-S"
      }
    }
  ]
}